Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study
- PMID: 31111143
- DOI: 10.1093/brain/awz111
Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study
Abstract
Parkinson's disease has a long prodromal stage with various subclinical motor and non-motor manifestations; however, their evolution in the years before Parkinson's disease is diagnosed is unclear. We traced the evolution of early motor and non-motor manifestations of synucleinopathy from the stage of idiopathic rapid eye movement (REM) sleep behaviour disorder until defined neurodegenerative disease. During 2004-16, we recruited and then annually followed 154 polysomnography-proven patients with idiopathic REM sleep behaviour disorder, of whom 55 phenoconverted to defined parkinsonism or dementia. Longitudinal data on multiple prodromal features, including the Unified Parkinson's Disease Rating Scale parts I-III, quantitative motor tests, olfaction, colour vision, cognition, and autonomic functions were gathered annually (average = five follow-up visits, range: 2-12 years). The same measures were also assessed in 102 age- and sex-matched healthy control subjects. By looking backward from the time of dementia or parkinsonism diagnosis, we examined trajectories of each prodromal feature using mixed effect models. Based on analysis, olfactory loss was first to develop, with predicted onset >20 years before phenoconversion. This was followed by impaired colour vision, constipation, and erectile dysfunction, starting 10-16 years prior to phenoconversion. At 7-9 years before phenoconversion, slight urinary dysfunction and subtle cognitive decline could be detected. Among motor symptoms altered handwriting, turning in bed, walking, salivation, speech, and facial expression began to be disrupted starting 7-11 years prior to parkinsonism diagnosis, but remained mild until soon before phenoconversion. Motor examination abnormalities began 5-7 years before phenoconversion, with the alternate tap test having the longest interval (8 years before phenoconversion). Among cardinal motor phenotypes, bradykinesia appeared first, ∼5-6 years prior to phenoconversion, followed by rigidity (Year -3) and tremor (Year -2). With direct prospective evaluation of an idiopathic REM sleep behaviour disorder cohort during phenoconversion, we documented an evolution of prodromal manifestations similar to that predicted by pathological staging models, with predicted prodromal intervals as long as 20 years.
Keywords: evolution; parkinsonism; prodromal stage; rapid-eye-movement (REM) sleep behaviour disorder (RBD).
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Comment in
-
From dreams to parkinsonism: tracking the journey.Brain. 2019 Jul 1;142(7):1850-1852. doi: 10.1093/brain/awz155. Brain. 2019. PMID: 31505543 Free PMC article.
Similar articles
-
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.Brain. 2012 Jun;135(Pt 6):1860-70. doi: 10.1093/brain/aws093. Epub 2012 May 4. Brain. 2012. PMID: 22561644
-
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.Brain. 2023 Aug 1;146(8):3258-3272. doi: 10.1093/brain/awad072. Brain. 2023. PMID: 36881989
-
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030. Brain. 2019. PMID: 30789229 Free PMC article. Clinical Trial.
-
REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.Mov Disord. 2017 May;32(5):645-658. doi: 10.1002/mds.27018. Mov Disord. 2017. PMID: 28513079 Review.
-
Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.Lancet Neurol. 2013 May;12(5):469-82. doi: 10.1016/S1474-4422(13)70054-1. Epub 2013 Apr 9. Lancet Neurol. 2013. PMID: 23578773 Free PMC article. Review.
Cited by
-
Clinical symptoms and neuroanatomical substrates of daytime sleepiness in Parkinson's disease.NPJ Parkinsons Dis. 2024 Aug 9;10(1):149. doi: 10.1038/s41531-024-00734-x. NPJ Parkinsons Dis. 2024. PMID: 39122721 Free PMC article.
-
Rate of motor progression in Parkinson's disease: a systematic review and meta-analysis.Front Neurol. 2024 Sep 26;15:1452741. doi: 10.3389/fneur.2024.1452741. eCollection 2024. Front Neurol. 2024. PMID: 39391167 Free PMC article.
-
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-Viewpoint.Front Neurol. 2020 Jun 12;11:556. doi: 10.3389/fneur.2020.00556. eCollection 2020. Front Neurol. 2020. PMID: 32595595 Free PMC article.
-
Identifying Subtle Motor Deficits Before Parkinson's Disease is Diagnosed: What to Look for?J Parkinsons Dis. 2024;14(s2):S287-S296. doi: 10.3233/JPD-230350. J Parkinsons Dis. 2024. PMID: 38363620 Free PMC article. Review.
-
MicroRNA-409-3p Targeting at ATXN3 Reduces the Apoptosis of Dopamine Neurons Based on the Profile of miRNAs in the Cerebrospinal Fluid of Early Parkinson's Disease.Front Cell Dev Biol. 2022 Jan 10;9:755254. doi: 10.3389/fcell.2021.755254. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35111747 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous